Biotech ApS Wg, Director at Y-mAbs Therapeutics, Inc. (YMAB), bought 242,732 shares at $6.99 ($1.7M) on 2023-12-08, disclosed to the SEC on 2023-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.99 | 18,503 | $129K | 7.6% |
| 2 | $6.99 | 18,503 | $129K | 7.6% |
| 3 | $7.01 | 102,863 | $721K | 42.4% |
| 4 | $7.01 | 102,863 | $721K | 42.4% |
| Total | $7.01 avg | 242,732 | $1.7M | 100% |
| Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |
| YMAB | SELL | 2021-06-11 | $812K | — | Filing → |